Ilyin VI - Search Results

1

A-317491, a selective P2X3/P2X2/3 receptor antagonist, reverses inflammatory mechanical hyperalgesia through action at peripheral receptors in rats.

Wu G, Whiteside GT, Lee G, Nolan S, Niosi M, Pearson MS, Ilyin VI. Wu G, et al. Among authors: ilyin vi. Eur J Pharmacol. 2004 Nov 3;504(1-2):45-53. doi: 10.1016/j.ejphar.2004.09.056. Eur J Pharmacol. 2004. PMID: 15507220

2

Pharmacology of 2-[4-(4-chloro-2-fluorophenoxy)phenyl]-pyrimidine-4-carboxamide: a potent, broad-spectrum state-dependent sodium channel blocker for treating pain states.

Ilyin VI, Pomonis JD, Whiteside GT, Harrison JE, Pearson MS, Mark L, Turchin PI, Gottshall S, Carter RB, Nguyen P, Hogenkamp DJ, Olanrewaju S, Benjamin E, Woodward RM. Ilyin VI, et al. J Pharmacol Exp Ther. 2006 Sep;318(3):1083-93. doi: 10.1124/jpet.106.104737. Epub 2006 May 25. J Pharmacol Exp Ther. 2006. PMID: 16728593

3

Cysteine racemization during the Fmoc solid phase peptide synthesis of the Nav1.7-selective peptide--protoxin II.

Park JH, Carlin KP, Wu G, Ilyin VI, Kyle DJ. Park JH, et al. Among authors: ilyin vi. J Pept Sci. 2012 Jul;18(7):442-8. doi: 10.1002/psc.2407. Epub 2012 May 17. J Pept Sci. 2012. PMID: 22605564

4

Phenylarsine oxide as a redox modulator of transient receptor potential vanilloid type 1 channel function.

Carlin KP, Wu G, Patel A, Crumley G, Ilyin VI. Carlin KP, et al. Among authors: ilyin vi. J Neurosci Res. 2015 Feb;93(2):309-20. doi: 10.1002/jnr.23479. Epub 2014 Sep 24. J Neurosci Res. 2015. PMID: 25250537

5

Studies examining the relationship between the chemical structure of protoxin II and its activity on voltage gated sodium channels.

Park JH, Carlin KP, Wu G, Ilyin VI, Musza LL, Blake PR, Kyle DJ. Park JH, et al. Among authors: ilyin vi. J Med Chem. 2014 Aug 14;57(15):6623-31. doi: 10.1021/jm500687u. Epub 2014 Jul 24. J Med Chem. 2014. PMID: 25026046

6

V102862 (Co 102862): a potent, broad-spectrum state-dependent blocker of mammalian voltage-gated sodium channels.

Ilyin VI, Hodges DD, Whittemore ER, Carter RB, Cai SX, Woodward RM. Ilyin VI, et al. Br J Pharmacol. 2005 Mar;144(6):801-12. doi: 10.1038/sj.bjp.0706058. Br J Pharmacol. 2005. PMID: 15778702 Free PMC article.

7

Pharmacology of ACEA-1416: a potent systemically active NMDA receptor glycine site antagonist.

Ilyin VI, Whittemore ER, Tran M, Shen KZ, Cai SX, Kher SM, Keana JF, Weber E, Woodward RM. Ilyin VI, et al. Eur J Pharmacol. 1996 Aug 29;310(2-3):107-14. doi: 10.1016/0014-2999(96)00370-6. Eur J Pharmacol. 1996. PMID: 8884205

8

Phenoxyphenyl pyridines as novel state-dependent, high-potency sodium channel inhibitors.

Shao B, Victory S, Ilyin VI, Goehring RR, Sun Q, Hogenkamp D, Hodges DD, Islam K, Sha D, Zhang C, Nguyen P, Robledo S, Sakellaropoulos G, Carter RB. Shao B, et al. Among authors: ilyin vi. J Med Chem. 2004 Aug 12;47(17):4277-85. doi: 10.1021/jm040048d. J Med Chem. 2004. PMID: 15293999

9

Subtype-selective antagonism of NMDA receptors by nylidrin.

Whittemore ER, Ilyin VI, Konkoy CS, Woodward RM. Whittemore ER, et al. Among authors: ilyin vi. Eur J Pharmacol. 1997 Oct 22;337(2-3):197-208. doi: 10.1016/s0014-2999(97)01292-2. Eur J Pharmacol. 1997. PMID: 9430414

10

Pharmacological characterization of recombinant N-type calcium channel (Cav2.2) mediated calcium mobilization using FLIPR.

Benjamin ER, Pruthi F, Olanrewaju S, Shan S, Hanway D, Liu X, Cerne R, Lavery D, Valenzano KJ, Woodward RM, Ilyin VI. Benjamin ER, et al. Among authors: ilyin vi. Biochem Pharmacol. 2006 Sep 14;72(6):770-82. doi: 10.1016/j.bcp.2006.06.003. Epub 2006 Jul 17. Biochem Pharmacol. 2006. PMID: 16844100

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters